糖心视频

Publications

Cook Gemma C, McKay Blandine, , Edwards Lee J, Harriman Charlotte, Read Zackary S, Bate Simon T

Chemistry - A European Journal (2026)

Livingstone Connor, Nicolle Simon, Jones Gavin,

Bioconjugate Chemistry Vol 37, pp. 40-51 (2026)

Chen Luke, Thompson James David Francis,

Advanced Synthesis and Catalysis Vol 367 (2025)

Gounis Michalis, Campos America V, Shokry Engy, Mitchell Louise, Deshmukh Ruhi, Dornier Emmanuel, Rooney Nicholas, Dhayade Sandeep, Pardo Luis, Moore Madeleine, Novo David, Mowat Jenna, , Kay Emily, Zanivan Sara, Paul Nikki R, Mitchell Claire, Nixon Colin, Macpherson Iain, Tardito Saverio, Sumpton David, Blyth Karen, Norman Jim C, Clarke Cassie J

Journal of Cell Biology Vol 224 (2025)

, Watson Joe, Richards Stephen, , Seki Hikaru, Love Elizabeth A, Coles Charlotte H, Coe Diane M,

Bioconjugate Chemistry Vol 36, pp. 1054-1065 (2025)

Hunter Irene, , McEwan Iain

Endocrine Oncology Vol 5 (2025)

Research Interests

Biography

Craig Jamieson earned his BSc (Hons) in Chemistry at the University of Glasgow in 1996. His PhD studies were carried out under the direction of Professor R Ramage at the University of Edinburgh (1999).聽 Following postdoctoral research under the supervision of Professor S V Ley at the University of Cambridge, in 2001 he was appointed as a Principal Scientist in GlaxoSmithKline's Discovery Medicinal Chemistry group working on a range of exploratory medicinal chemistry programmes.聽 In 2004, Craig joined Organon Laboratories (later Merck Research Labs) as a Group Leader in the Medicinal Chemistry Department, with responsibility for hit to clincal candidate optimisation.聽 In August 2010, Craig was appointed as a John Anderson Research Lecturer in Chemical Biology, based in the Department of Pure and Applied Chemistry at the 糖心视频 where he is currently a Professor in the Chemical Biology and Medicinal Chemistry Research Theme.

Research Interests

A major area of focus for our research continues to be in the Chemistry-Biology-Medicine continuum.聽 In this regard, we have a number of active programmes centred around hit and lead identification on disease targets and mechanisms in areas of significant societal need.聽 Allied to our work in the medicinal chemistry sphere, we also have a keen interest in the development of novel, enabling synthetic methodologies to enhance the armamentarium of molecule makers working in our arena.聽 We collaborate with groups and industrial partners locally, nationally and globally in order to effectively meet our research goals.

Professional Activities

Consultant

3/2025

Contributor

23/11/2022

Visiting researcher

1/6/2019

Visiting researcher

31/5/2019

Consultant

1/10/2018

Consultant

1/1/2016

Projects

Jamieson, Craig (Co-investigator)

01-Jan-2025 - 30-Jan-2030

Marshall, Helina (Principal Investigator) Jamieson, Craig (Principal Investigator)

01-Jan-2025

Jamieson, Craig (Principal Investigator) Beveridge, Rebecca (Co-investigator) Burley, Glenn (Co-investigator) Kerr, William (Co-investigator) Lindsay, David (Co-investigator) Palmer, David (Co-investigator) Tomkinson, Nick (Co-investigator)

01-Jan-2025 - 31-Jan-2030

Jamieson, Craig (Principal Investigator)

01-Jan-2025 - 28-Jan-2026

Jamieson, Craig (Principal Investigator) Kerr, William (Co-investigator) Reid, Andrew (Research Co-investigator)

01-Jan-2024 - 01-Jan-2028

Jamieson, Craig (Principal Investigator) Chow, Shiao (Co-investigator) O'Brien, Megan (Research Co-investigator)

01-Jan-2024 - 01-Jan-2025